VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ADPT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ADPTAdaptive Biotechnologies Corporation
$28.49$4.6B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksADPTRevenue History

ADPT logoAdaptive Biotechnologies Corporation (ADPT) Revenue History

Annual and quarterly revenue from 2017 to present

TTM Revenue$298.0M▲ +$21.0M vs FY2025
YoY Growth-10.7%Declining
Q3 2026$83.9M-10.7% YoY · +17.3% QoQ
Revenue CAGR
3Y+14.3%
→
5Y+23.0%
→
10Y—
Growth decelerating ↓
Best Fiscal Year$277.0M (2025)
Best Quarter$94.0M (Q3 2025)
Revenue per Share$1.86
Revenue per Employee$478K

ADPT Revenue Over Time (2017–2025)

ADPT Revenue Growth History

7 of 8 years with positive growth
Annual Revenue Growth · Each cell = one fiscal year
2017—
2018+44.8%
2019+52.8%
2020+15.6%
2021+56.9%
2022+20.1%
2023-8.1%
2024+5.1%
2025+54.8%
FY2017 revenue growth
N/A
FY2018 revenue growth
+44.8%
FY2019 revenue growth
+52.8%
FY2020 revenue growth
+15.6%
FY2021 revenue growth
+56.9%
FY2022 revenue growth
+20.1%
FY2023 revenue growth
-8.1%
FY2024 revenue growth
+5.1%
FY2025 revenue growth
+54.8%
DeclineStrong growth
↑ 2-year growth streakBest: +56.9% (FY2021)Worst: -8.1% (FY2023)
Recent Quarterly Revenue & YoY Growth
QuarterRevenueYoY
Q3 2026$83.9M-10.7%
Q2 2026$71.6M+21.5%
Q1 2026$70.9M+35.1%
Q4 2025$71.7M+51.0%
Q3 2025$94.0M+102.4%
Q2 2025$58.9M+36.3%
Q1 2025$52.4M+25.2%
Q4 2024$47.5M+3.7%
Seasonal Revenue Pattern (fiscal quarters)
Q1
21%
Q2
24%
Q3
27%
Q4
28%

Multi-year avg. share of annual revenue by fiscal quarter

Revenue Breakdown (FY 2021)

ADPT's revenue distribution by segment and geography for fiscal year 2021

By Product/Segment

Sequencing Revenue51.1%
Development Support Revenue42.4%
Development Revenue Regulatory Milestones6.5%

ADPT Revenue Analysis (2017–2025)

Current Revenue & Growth

As of November 19, 2026, Adaptive Biotechnologies Corporation (ADPT) generated trailing twelve-month (TTM) revenue of $298.0 million, reflecting significant decline in growth of -10.7% year-over-year. The most recent quarter (Q3 2026) recorded $83.9 million in revenue, up 17.3% sequentially.

Historical Growth Trajectory

ADPT's 5-year compound annual growth rate (CAGR) stands at +23.0%, indicating outstanding long-term growth trajectory. The 3-year CAGR of +14.3% is below the 5-year average, signalling a growth deceleration in recent years. Adaptive Biotechnologies Corporation's highest annual revenue of $277.0 million was recorded in 2025, an all-time high.

Revenue by Segment

ADPT's revenue is primarily driven by Sequencing Revenue (51%), Development Support Revenue (42%), and Development Revenue Regulatory Milestones (6%). With over half of revenue concentrated in Sequencing Revenue, the company has a focused business model while developing other growth vectors.

Peer Comparison

Compared to Healthcare sector peers — including NTRA (+37.4% YoY), PACB (+4.4% YoY), and TWST (+22.0% YoY) — ADPT has underperformed the peer group in revenue growth. Compare ADPT vs NTRA →

ADPT Revenue vs Peers

Revenue metrics vs comparable public companies

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
ADPT logoADPTCurrent$298M-10.7%+23.0%-20.6%
NTRA logoNTRA$2.3B+37.4%+42.6%-13.4%
PACB logoPACB$160M+4.4%+15.2%-348.5%
TWST logoTWST$459M+22.0%+28.3%-30.4%
ILMN logoILMN$4.3B+5.9%+6.0%19.9%
FLGT logoFLGT$323M+4.7%-5.2%-28.2%
Best in groupLowest in group

ADPT Historical Revenue Data (2017–2025)

1–9 of 9 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2025$277.0M+54.8%$205.6M74.2%$-57,123,000-20.6%
2024$179.0M+5.1%$106.9M59.7%$-162,549,000-90.8%
2023$170.3M-8.1%$94.7M55.6%$-227,035,000-133.3%
2022$185.3M+20.1%$127.4M68.7%$-200,186,000-108.0%
2021$154.3M+56.9%$105.0M68.1%$-208,966,000-135.4%
2020$98.4M+15.6%$75.9M77.1%$-152,817,000-155.3%
2019$85.1M+52.8%$62.8M73.8%$-78,391,000-92.1%
2018$55.7M+44.8%$36.0M64.7%$-49,756,000-89.4%
2017$38.4M-$22.8M59.2%$-44,475,000-115.7%
Consensus & Technical Research Suite
Open ADPT Terminal

ADPT Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

9+ years return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

ADPT — Frequently Asked Questions

Quick answers to the most common questions about buying ADPT stock.

Is ADPT's revenue growth accelerating or slowing?

ADPT revenue is declining -10.7% year-over-year. TTM revenue fell to $298M, contrasting with the 5-year CAGR of +23.0%. The reversal reflects either macro headwinds or company-specific challenges.

What is ADPT's revenue history from 2017 to 2026?

Adaptive Biotechnologies Corporation (ADPT) revenue history spans 2017 to 2026. TTM revenue as of 2026 is $298M, growing at -10.7% YoY. The 5-year CAGR is +23.0%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.

What is ADPT's long-term revenue growth rate (CAGR)?

Adaptive Biotechnologies Corporation's 5-year revenue CAGR of +23.0% reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of -10.7% is below this long-term average. CAGR is the most reliable measure of sustained revenue momentum for ADPT.

Why does ADPT's quarterly revenue fluctuate?

ADPT quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Adaptive Biotechnologies Corporation's revenue data from 2017 to 2026 shows full historical quarterly detail on this page.

How is ADPT's revenue distributed by segment?

ADPT reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.

How does ADPT's revenue compare to industry peers?

Adaptive Biotechnologies Corporation (ADPT) with TTM revenue of $298M and -10.7% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.